Clinvest is a research organization dedicated to the advancement of medicine and health management through clinical research. Founded by Dr. Roger Cady in 1996, Clinvest began as a research office associated with a small, independent primary care and headache specialty clinic located in Springfield, Missouri. Dr. Cady’s vision was to explore concepts sparked by information gathered in a clinical setting. Combining his clinical expertise in headache and his understanding of the value of patient reporting, Clinvest was formed. The results of many of those early migraine trials have revolutionized our understanding and treatment of migraine today.
As a Clinical Research Site
Clinvest is a dedicated medical research facility that’s passionate about new concepts for disease control and prevention. We work with some of the nation’s top headache specialists, as well as other specialty physicians in the Springfield, Missouri area. We conduct FDA Phase II-IV research at our conveniently located, state-of-the-art facility. The majority of the research studies conducted at Clinvest are multi-center national or world-wide studies involving hundreds to thousands of participants. Our dedicated team of research professionals is committed to excellence, making us a leader in the field of Clinical Research. Clinvest Clinical Research has conducted more than 400 clinical trials sponsored by leading global pharmaceutical companies in a number of research areas including headache, hypertension, diabetes, osteoarthritis, GI disorders, Alzheimer’s disease, fibromyalgia, herpes simplex, asthma, low back pain, inflammatory bio-markers, and hyperlipidemia.